HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry.

Abstract
We present a highly sensitive, rapid method for the determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine. The method is based on the quantification of ruthenium by inductively coupled plasma mass spectrometry and allows quantification of 30 ng L(-1) ruthenium in plasma ultrafiltrate and urine, and 75 ng L(-1) ruthenium in human plasma, in 150 microL of matrix. The sample pretreatment procedure is straightforward and only involves dilution with appropriate diluents. The performance of the method, in terms of accuracy and precision, fulfilled the most recent FDA guidelines for bioanalytical method validation. Validated ranges of quantification were 30.0 to 1 x 10(4) ng L(-1) for ruthenium in plasma ultrafiltrate and urine and 75.0 to 1 x 10(4) ng L(-1) for ruthenium in plasma. The applicability of the method and its superiority to atomic-absorption spectrometry were demonstrated in two patients who were treated with intravenous NAMI-A in a phase I trial. The assay is now successfully used to support pharmacokinetic studies in cancer patients treated with NAMI-A.
AuthorsElke E M Brouwers, Matthijs M Tibben, Hilde Rosing, Jan H M Schellens, Jos H Beijnen
JournalRapid communications in mass spectrometry : RCM (Rapid Commun Mass Spectrom) Vol. 21 Issue 9 Pg. 1521-30 ( 2007) ISSN: 0951-4198 [Print] England
PMID17410551 (Publication Type: Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
CopyrightCopyright 2007 John Wiley & Sons, Ltd.
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • Ruthenium Compounds
  • imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)
  • Ruthenium
  • Dimethyl Sulfoxide
Topics
  • Antineoplastic Agents (blood, pharmacokinetics, urine)
  • Area Under Curve
  • Dimethyl Sulfoxide (analogs & derivatives, blood, pharmacokinetics, urine)
  • Half-Life
  • Humans
  • Mass Spectrometry (methods)
  • Organometallic Compounds (blood, pharmacokinetics, urine)
  • Reproducibility of Results
  • Ruthenium (analysis)
  • Ruthenium Compounds

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: